Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totaling 8,434 shares, an increase of 35.6% from the December 15th total of 6,218 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average daily volume of 11,018 shares, the days-to-cover ratio is presently 0.8 days. Based on an average daily volume of 11,018 shares, the days-to-cover ratio is presently 0.8 days. Currently, 0.1% of the shares of the company are sold short.
Analyst Ratings Changes
Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Oxbridge Re in a research report on Wednesday, October 8th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $5.00.
Get Our Latest Stock Analysis on Oxbridge Re
Hedge Funds Weigh In On Oxbridge Re
Oxbridge Re Stock Performance
OXBR traded up $0.00 during mid-day trading on Friday, reaching $1.23. The stock had a trading volume of 12,812 shares, compared to its average volume of 8,534. The firm’s fifty day simple moving average is $1.31 and its two-hundred day simple moving average is $1.72. The stock has a market capitalization of $9.43 million, a P/E ratio of -3.61 and a beta of 2.14. Oxbridge Re has a 52 week low of $1.12 and a 52 week high of $5.81.
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last issued its quarterly earnings results on Thursday, November 6th. The insurance provider reported ($0.02) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.01). The business had revenue of $0.65 million for the quarter, compared to analyst estimates of $0.74 million. Oxbridge Re had a negative return on equity of 47.76% and a negative net margin of 109.74%.
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Further Reading
- Five stocks we like better than Oxbridge Re
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
